CA2075982A1 - Insulin compositions - Google Patents
Insulin compositionsInfo
- Publication number
- CA2075982A1 CA2075982A1 CA002075982A CA2075982A CA2075982A1 CA 2075982 A1 CA2075982 A1 CA 2075982A1 CA 002075982 A CA002075982 A CA 002075982A CA 2075982 A CA2075982 A CA 2075982A CA 2075982 A1 CA2075982 A1 CA 2075982A1
- Authority
- CA
- Canada
- Prior art keywords
- insulin
- iii
- ins
- general formula
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK045590A DK45590D0 (US07223432-20070529-C00017.png) | 1990-02-21 | 1990-02-21 | |
DK0455/90 | 1990-02-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2075982A1 true CA2075982A1 (en) | 1991-08-22 |
Family
ID=8093754
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002075982A Abandoned CA2075982A1 (en) | 1990-02-21 | 1991-02-21 | Insulin compositions |
Country Status (12)
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9316895D0 (en) * | 1993-08-13 | 1993-09-29 | Guy S And St Thomas Hospitals | Hepatoselective insulin analogues |
US6342225B1 (en) | 1993-08-13 | 2002-01-29 | Deutshces Wollforschungsinstitut | Pharmaceutical active conjugates |
US6011007A (en) * | 1993-09-17 | 2000-01-04 | Novo Nordisk A/S | Acylated insulin |
US6869930B1 (en) | 1993-09-17 | 2005-03-22 | Novo Nordisk A/S | Acylated insulin |
US6251856B1 (en) | 1995-03-17 | 2001-06-26 | Novo Nordisk A/S | Insulin derivatives |
US6451762B1 (en) | 1997-10-24 | 2002-09-17 | Novo Nordisk A/S | Aggregates of human insulin derivatives |
WO2005012347A2 (en) | 2003-08-05 | 2005-02-10 | Novo Nordisk A/S | Novel insulin derivatives |
RU2352581C2 (ru) | 2003-08-05 | 2009-04-20 | Ново Нордиск А/С | Производные инсулина |
ES2438145T3 (es) | 2005-02-02 | 2014-01-16 | Novo Nordisk A/S | Nuevos derivados de insulina |
EP2505593A1 (en) | 2005-12-28 | 2012-10-03 | Novo Nordisk A/S | Compositions comprising an acylated insulin and zinc and method of making the said compositions |
CN101573133B (zh) | 2006-07-31 | 2014-08-27 | 诺沃-诺迪斯克有限公司 | Peg化延长的胰岛素 |
BRPI0717098B8 (pt) | 2006-09-22 | 2021-05-25 | Novo Nordisk As | análogos de insulina humana resistentes à protease, composição farmacêutica e processo para sua preparação |
EP2502618A3 (en) | 2007-04-30 | 2012-10-03 | Novo Nordisk A/S | Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein |
CN101677947B (zh) | 2007-06-13 | 2013-07-17 | 诺沃-诺迪斯克有限公司 | 包含胰岛素衍生物的药物制剂 |
CN101970477B (zh) | 2008-03-14 | 2014-12-31 | 诺沃-诺迪斯克有限公司 | 蛋白酶稳定的胰岛素类似物 |
KR20110004366A (ko) | 2008-03-18 | 2011-01-13 | 노보 노르디스크 에이/에스 | 프로테아제 안정화되고, 아실화된 인슐린 유사체 |
US9603904B2 (en) | 2008-10-30 | 2017-03-28 | Novo Nordisk A/S | Treating diabetes melitus using insulin injections with less than daily injection frequency |
JP6049625B2 (ja) | 2010-10-27 | 2016-12-21 | ノヴォ ノルディスク アー/エス | 様々な注射間隔を用いて施されるインスリン注射を使用する、真性糖尿病の治療 |
ES2594303T3 (es) | 2012-04-11 | 2016-12-19 | Novo Nordisk A/S | Formulaciones de insulina |
US10137172B2 (en) | 2013-04-30 | 2018-11-27 | Novo Nordisk A/S | Administration regime |
US9896496B2 (en) | 2013-10-07 | 2018-02-20 | Novo Nordisk A/S | Derivative of an insulin analogue |
CN115154591B (zh) | 2016-12-16 | 2023-04-14 | 诺和诺德股份有限公司 | 含胰岛素的药物组合物 |
US10335464B1 (en) | 2018-06-26 | 2019-07-02 | Novo Nordisk A/S | Device for titrating basal insulin |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE971500C (de) * | 1950-11-22 | 1959-02-05 | Organon Nv | Verfahren zur Herstellung von Insulin-Suspensionen mit verlaengerter Wirkung |
DE1107374B (de) * | 1958-01-31 | 1961-05-25 | Organon Nv | Verfahren zur Herstellung eines Insulin-Praeparates |
-
1990
- 1990-02-21 DK DK045590A patent/DK45590D0/da not_active Application Discontinuation
-
1991
- 1991-02-20 IE IE057991A patent/IE910579A1/en unknown
- 1991-02-20 NZ NZ237176A patent/NZ237176A/en unknown
- 1991-02-21 DE DE91904980T patent/DE69100626D1/de not_active Expired - Lifetime
- 1991-02-21 ZA ZA911279A patent/ZA911279B/xx unknown
- 1991-02-21 AU AU73378/91A patent/AU641991B2/en not_active Expired - Fee Related
- 1991-02-21 EP EP91904980A patent/EP0516704B1/en not_active Expired - Lifetime
- 1991-02-21 PT PT96841A patent/PT96841A/pt not_active Application Discontinuation
- 1991-02-21 WO PCT/DK1991/000052 patent/WO1991012817A1/en active IP Right Grant
- 1991-02-21 JP JP3504590A patent/JPH05503940A/ja active Pending
- 1991-02-21 CA CA002075982A patent/CA2075982A1/en not_active Abandoned
- 1991-02-21 HU HU922721Q patent/HUT63858A/hu unknown
Also Published As
Publication number | Publication date |
---|---|
JPH05503940A (ja) | 1993-06-24 |
AU641991B2 (en) | 1993-10-07 |
AU7337891A (en) | 1991-09-18 |
PT96841A (pt) | 1991-11-29 |
IE910579A1 (en) | 1991-08-28 |
DK45590D0 (US07223432-20070529-C00017.png) | 1990-02-21 |
WO1991012817A1 (en) | 1991-09-05 |
ZA911279B (en) | 1991-10-30 |
HU9202721D0 (en) | 1992-12-28 |
EP0516704B1 (en) | 1993-11-10 |
HUT63858A (en) | 1993-10-28 |
DE69100626D1 (de) | 1993-12-16 |
EP0516704A1 (en) | 1992-12-09 |
NZ237176A (en) | 1991-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0516704B1 (en) | Novel insulin compositions | |
DE3885317T2 (de) | Makromolekulare Platin-Antitumorverbindungen. | |
US5456922A (en) | Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration of growth hormone | |
KR890004687B1 (ko) | 생물학적 활성 서방출성 조성물 | |
AU2004251625B2 (en) | Synthesis of high molecular weight iron-saccharidic complexes | |
DE69815877T2 (de) | Aggregate von menschlichen insulinderivaten | |
CA1094549A (en) | Therapeutic insulin preparation and a process for the production of a stable insulin preparation with protracted effect | |
JPH01502434A (ja) | 新規インシュリン誘導体 | |
EP0646379A1 (en) | Insulin formulation | |
IE61340B1 (en) | Stable interferon complexes | |
HU227992B1 (en) | Interferon conjugates, process for prepairing them, pharmaceutical compositions, containing them and use of them | |
CZ85790A3 (en) | Novel preparations containing associates of hyaluronic acid, and process for preparing thereof | |
EP2496213B1 (en) | Pharmaceutical solution of non covalently bound albumin and acylated insulin | |
EP2943216B1 (en) | Modified ace2 polypeptides | |
JPH04504117A (ja) | グリコシル化インシュリン | |
SA520420276B1 (ar) | تركيبات صيدلية تحتوي على الأنسولين | |
JPH10511365A (ja) | 遅延性glp−1組成物 | |
EP0119650A2 (en) | Galactosyl-insulin conjugates useful in treating diabetics | |
CA1335924C (en) | Mixed crystals of insulin and insulin derivatives, a process for the preparation of these mixed crystals, pharmaceutical agents containing these mixed crystals, and the use thereof for the treatment of diabetes mellitus | |
Enriquez et al. | Conjugation of adenine arabinoside 5'-monophosphate to arabinogalactan: synthesis, characterization, and antiviral activity | |
EP1308155B1 (en) | Injectable solution containing a colloid of iron and shark cartilage-derived chondroitin sulfate | |
EP1620072B1 (en) | Zinc-containing sustained-release composition, its preparation, and method for producing the same | |
JP2716497B2 (ja) | ヘモグロビン コンプレツクス | |
EP2026789A2 (de) | Neue, an der tumorphysiologie orientierte formulierung eines zytostatikums, insbesondere von cis-platin | |
DE2646223C2 (US07223432-20070529-C00017.png) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |